ConductScience.org, home

Trial · NCT02666664

Results by group178

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)PlaceboAny TEAE78.7percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)Bempedoic AcidAny TEAE78.5percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)PlaceboAny serious TEAE14.0percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)Bempedoic AcidAny serious TEAE14.5percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)PlaceboAny fatal TEAE0.3percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)Bempedoic AcidAny fatal TEAE0.9percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)PlaceboAny TEAE leading to discontinuation of study drug7.1percentage of participants
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)Bempedoic AcidAny TEAE leading to discontinuation of study drug10.9percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventPlaceboAny adjudicated major clinical event5.7percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventBempedoic AcidAny adjudicated major clinical event4.6percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventPlaceboAny TE death from cardiovascular causes0.1percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventBempedoic AcidAny TE death from cardiovascular causes0.4percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventPlaceboAny nonfatal myocardial infarction1.8percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventBempedoic AcidAny nonfatal myocardial infarction1.3percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventPlaceboAny nonfatal stroke0.3percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventBempedoic AcidAny nonfatal stroke0.3percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventPlaceboAny coronary revascularization3.2percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventBempedoic AcidAny coronary revascularization2.6percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventPlaceboAny hospitalization for unstable angina1.5percentage of participants
Percentage of Participants With Adjudicated Major Adverse Cardiovascular EventBempedoic AcidAny hospitalization for unstable angina0.9percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02666664/results